Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004501

General Counsel sold 2,573 shares at an average $5.09 ($13,101)

  • General Counsel gave 98,346 shares (gift)
  • General Counsel gave 98,346 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Edward General Counsel 2022-12-02 Gift −98,346 151,031 D: show line 1 in the form
Miller Edward General Counsel 2022-12-02 Gift +98,346 288,799 I: show line 2 in the form
Miller Edward General Counsel 2023-01-19 Sale −2,032 $5.08 $10,318 148,999 D: show line 3 in the form
Miller Edward General Counsel 2023-01-20 Sale −541 $5.14 $2,783 148,458 D: show line 4 in the form
Open-market sales · 2,573 sh · avg $5.09 · $13,101
Loading xslF345X03/doc4.xml…